ID: ALA5209431

Max Phase: Preclinical

Molecular Formula: C18H15N7O2S2

Molecular Weight: 425.50

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2[nH]c(Sc3nc4c(c(=O)[nH]c(=O)n4C)n3Cc3cncs3)nc2c1

Standard InChI:  InChI=1S/C18H15N7O2S2/c1-9-3-4-11-12(5-9)21-16(20-11)29-18-22-14-13(15(26)23-17(27)24(14)2)25(18)7-10-6-19-8-28-10/h3-6,8H,7H2,1-2H3,(H,20,21)(H,23,26,27)

Standard InChI Key:  ABBSGFODBZCZGU-UHFFFAOYSA-N

Associated Targets(Human)

Tryptophan 5-hydroxylase 1 286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tryptophan 5-hydroxylase 2 43 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 425.50Molecular Weight (Monoisotopic): 425.0729AlogP: 2.26#Rotatable Bonds: 4
Polar Surface Area: 114.25Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.12CX Basic pKa: 4.09CX LogP: 3.10CX LogD: 3.10
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -2.03

References

1. Specker E, Matthes S, Wesolowski R, Schütz A, Grohmann M, Alenina N, Pleimes D, Mallow K, Neuenschwander M, Gogolin A, Weise M, Pfeifer J, Ziebart N, Heinemann U, von Kries JP, Nazaré M, Bader M..  (2022)  Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.,  65  (16.0): [PMID:35921615] [10.1021/acs.jmedchem.2c00598]

Source